272 related articles for article (PubMed ID: 17674415)
1. Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial.
Mendonça DA; Menezes K; Jog MS
Mov Disord; 2007 Oct; 22(14):2070-6. PubMed ID: 17674415
[TBL] [Abstract][Full Text] [Related]
2. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
3. Using modafinil to treat fatigue in Parkinson disease: a double-blind, placebo-controlled pilot study.
Lou JS; Dimitrova DM; Park BS; Johnson SC; Eaton R; Arnold G; Nutt JG
Clin Neuropharmacol; 2009; 32(6):305-10. PubMed ID: 19620846
[TBL] [Abstract][Full Text] [Related]
4. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
5. Does methylphenidate reduce the symptoms of chronic fatigue syndrome?
Blockmans D; Persoons P; Van Houdenhove B; Bobbaers H
Am J Med; 2006 Feb; 119(2):167.e23-30. PubMed ID: 16443425
[TBL] [Abstract][Full Text] [Related]
6. A phase III, double-blind, placebo-controlled prospective randomized clinical trial of d-threo-methylphenidate HCl in brain tumor patients receiving radiation therapy.
Butler JM; Case LD; Atkins J; Frizzell B; Sanders G; Griffin P; Lesser G; McMullen K; McQuellon R; Naughton M; Rapp S; Stieber V; Shaw EG
Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1496-501. PubMed ID: 17869448
[TBL] [Abstract][Full Text] [Related]
7. Effects of methylphenidate on response to oral levodopa: a double-blind clinical trial.
Nutt JG; Carter JH; Carlson NE
Arch Neurol; 2007 Mar; 64(3):319-23. PubMed ID: 17353373
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
9. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study.
Rabkin JG; Gordon PH; McElhiney M; Rabkin R; Chew S; Mitsumoto H
Muscle Nerve; 2009 Mar; 39(3):297-303. PubMed ID: 19208404
[TBL] [Abstract][Full Text] [Related]
10. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dexmethylphenidate for the treatment of fatigue after cancer chemotherapy: a randomized clinical trial.
Lower EE; Fleishman S; Cooper A; Zeldis J; Faleck H; Yu Z; Manning D
J Pain Symptom Manage; 2009 Nov; 38(5):650-62. PubMed ID: 19896571
[TBL] [Abstract][Full Text] [Related]
12. Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study.
Lou JS; Kearns G; Benice T; Oken B; Sexton G; Nutt J
Mov Disord; 2003 Oct; 18(10):1108-14. PubMed ID: 14534913
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and tolerability of a 20-mg dose of methylphenidate for the treatment of daytime sleepiness in adult patients with myotonic dystrophy type 1: a 2-center, randomized, double-blind, placebo-controlled, 3-week crossover trial.
Puymirat J; Bouchard JP; Mathieu J
Clin Ther; 2012 May; 34(5):1103-11. PubMed ID: 22578232
[TBL] [Abstract][Full Text] [Related]
14. Randomized controlled trial of modafinil for the treatment of fatigue in postpolio patients.
Chan KM; Strohschein FJ; Rydz D; Allidina A; Shuaib A; Westbury CF
Muscle Nerve; 2006 Jan; 33(1):138-41. PubMed ID: 16175627
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder.
Medori R; Ramos-Quiroga JA; Casas M; Kooij JJ; Niemelä A; Trott GE; Lee E; Buitelaar JK
Biol Psychiatry; 2008 May; 63(10):981-9. PubMed ID: 18206857
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled crossover trial of ondansetron in patients with primary biliary cirrhosis and fatigue.
Theal JJ; Toosi MN; Girlan L; Heslegrave RJ; Huet PM; Burak KW; Swain M; Tomlinson GA; Heathcote EJ
Hepatology; 2005 Jun; 41(6):1305-12. PubMed ID: 15915460
[TBL] [Abstract][Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
Lizogub VG; Riley DS; Heger M
Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate for the treatment of apathy in Alzheimer disease: prediction of response using dextroamphetamine challenge.
Herrmann N; Rothenburg LS; Black SE; Ryan M; Liu BA; Busto UE; Lanctôt KL
J Clin Psychopharmacol; 2008 Jun; 28(3):296-301. PubMed ID: 18480686
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease.
Storch A; Jost WH; Vieregge P; Spiegel J; Greulich W; Durner J; Müller T; Kupsch A; Henningsen H; Oertel WH; Fuchs G; Kuhn W; Niklowitz P; Koch R; Herting B; Reichmann H;
Arch Neurol; 2007 Jul; 64(7):938-44. PubMed ID: 17502459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
